ACS 180/ADVIA CENTAUR AFP IMMUNOASSAY

Kit, Test, Alpha-fetoprotein For Neural Tube Defects

FDA Premarket Approval P930036 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the acs:180 and the centaur afp assays on the advia centaur cp system. The device, as modified, will be marketed under the trade name advia centaur cp afp and is indicated for in vitro diagnostic use in the quantitative determination of alpha-fetoprotein (afp) in 1) human serum and in amniotic fluid from specimens obtained at 15 and 20 weeks gestation, as an aid in detecting open neural tube defects (ntds) when used in conjunction with ultrasonography and amniography testing 2) human serum, as an aid in managing non-seminomatous testicular cancer when used in conjunction with physical examination, histology/pathology, and other clinical evaluation procedures, using the (bayer) system.

DeviceACS 180/ADVIA CENTAUR AFP IMMUNOASSAY
Classification NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
Generic NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS INC.
Date Received2005-07-22
Decision Date2005-10-07
PMAP930036
SupplementS003
Product CodeLOK
Advisory CommitteeImmunology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS INC. 333 Coney Street east Walpole, MA 02032

Supplemental Filings

Supplement NumberDateSupplement Type
P930036Original Filing
S020 2022-09-01 30-day Notice
S019 2022-03-22 30-day Notice
S018 2021-08-11 Real-time Process
S017 2021-07-26 30-day Notice
S016 2021-04-01 30-day Notice
S015 2020-07-31 30-day Notice
S014 2020-03-09 30-day Notice
S013 2020-02-21 30-day Notice
S012
S011 2019-02-01 30-day Notice
S010 2018-12-06 Normal 180 Day Track
S009 2018-07-27 Real-time Process
S008 2017-09-01 Normal 180 Day Track
S007 2016-10-20 135 Review Track For 30-day Notice
S006 2015-07-17 Normal 180 Day Track
S005 2012-03-26 Normal 180 Day Track No User Fee
S004 2012-02-15 135 Review Track For 30-day Notice
S003 2005-07-22 Real-time Process
S002 2002-01-16 Real-time Process
S001 1998-05-01 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00630414597720 P930036 001
00630414124797 P930036 001
00630414124933 P930036 001
00630414124940 P930036 001
00630414126319 P930036 001
00630414177328 P930036 001
00630414177335 P930036 001
00630414022963 P930036 001
00630414238791 P930036 008
00630414238807 P930036 008

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.